Zuo et al. [25] |
“Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization” |
2020 |
Gastroenterology |
580 |
Yeoh et al. [22] |
“Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19” |
2021 |
Gut |
334 |
Dhar and Mohanty [17] |
“Gut microbiota and Covid-19—possible link and implications” |
2020 |
Virus Research |
313 |
Gu et al. [18] |
“Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza” |
2020 |
Clinical Infectious Diseases |
296 |
Zuo et al. [23] |
“Depicting SARS-CoV-2 fecal viral activity in association with gut microbiota composition in patients with COVID-19” |
2021 |
Gut |
196 |
Zuo et al. [24] |
“Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge” |
2020 |
Gastroenterology |
137 |
Saleh et al. [20] |
“Mitochondria and microbiota dysfunction in COVID-19 pathogenesis” |
2020 |
Mitochondrion |
134 |
Villapol [21] |
“Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome” |
2020 |
Translational Research |
133 |
Baud et al. [16] |
“Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic” |
2020 |
Frontiers in Public Health |
114 |
Infusino et al. [19] |
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: A scoping review |
2020 |
Nutrients |
107 |
Mak et al. [67] |
“Probiotics and COVID-19: one size does not fit all” |
2020 |
The Lancet Gastroenterology and Hepatology |
102 |